Christopher R. Cogle

8.4k total citations
162 papers, 3.5k citations indexed

About

Christopher R. Cogle is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Christopher R. Cogle has authored 162 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 56 papers in Molecular Biology and 47 papers in Genetics. Recurrent topics in Christopher R. Cogle's work include Acute Myeloid Leukemia Research (77 papers), Hematopoietic Stem Cell Transplantation (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers). Christopher R. Cogle is often cited by papers focused on Acute Myeloid Leukemia Research (77 papers), Hematopoietic Stem Cell Transplantation (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers). Christopher R. Cogle collaborates with scholars based in United States, United Kingdom and Hungary. Christopher R. Cogle's co-authors include Edward W. Scott, Alan F. List, John R. Wingard, Dana E. Rollison, Benjamin M. Craig, Guillermo Garcia‐Manero, Dani S. Zander, Grant McFadden, Jan S. Moreb and Dennis A. Steindler and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Christopher R. Cogle

153 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher R. Cogle United States	32	1.5k	1.5k	836	829	455	162	3.5k
Gerwin Huls Netherlands	30	1.3k 0.8×	1.9k 1.3×	435 0.5×	1.1k 1.3×	749 1.6×	115	3.9k
Johan Richter Sweden	36	1.7k 1.2×	1.5k 1.0×	1.2k 1.4×	851 1.0×	773 1.7×	145	4.2k
Ali G. Turhan France	37	2.0k 1.3×	1.5k 1.0×	1.4k 1.7×	1.0k 1.2×	473 1.0×	184	4.0k
Rainer Claus Germany	32	926 0.6×	2.6k 1.7×	534 0.6×	614 0.7×	467 1.0×	132	4.1k
Keyvan Keyvanfar United States	35	1.5k 1.0×	1.3k 0.9×	645 0.8×	786 0.9×	1.6k 3.6×	110	4.1k
Yogen Saunthararajah United States	38	2.8k 1.8×	2.7k 1.8×	1.4k 1.7×	584 0.7×	804 1.8×	164	5.1k
Josep Nomdedéu Spain	32	1.6k 1.1×	1.4k 1.0×	707 0.8×	736 0.9×	558 1.2×	131	3.5k
Wei Tong United States	34	1.7k 1.1×	2.7k 1.8×	1.8k 2.1×	948 1.1×	1.1k 2.5×	84	5.6k
Mark Wunderlich United States	32	1.9k 1.2×	2.9k 2.0×	323 0.4×	734 0.9×	653 1.4×	92	4.3k
Kirsten Grønbæk Denmark	42	1.0k 0.7×	3.1k 2.1×	914 1.1×	1.4k 1.7×	930 2.0×	191	5.9k

Countries citing papers authored by Christopher R. Cogle

Since Specialization

Citations

This map shows the geographic impact of Christopher R. Cogle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Cogle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Cogle more than expected).

Fields of papers citing papers by Christopher R. Cogle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Cogle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Cogle. The network helps show where Christopher R. Cogle may publish in the future.

Co-authorship network of co-authors of Christopher R. Cogle

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Cogle. A scholar is included among the top collaborators of Christopher R. Cogle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Cogle. Christopher R. Cogle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salloum, Ramzi G., Jonathan B. Bricker, Ji‐Hyun Lee, et al.. (2023). Comparative effectiveness of mobile health smoking cessation approaches among underserved patients in primary care: Study protocol for the PROMOTE-UP trial. Contemporary Clinical Trials. 127. 107120–107120. 2 indexed citations

Wang, Ruixuan, Jaclyn Hall, Ramzi G. Salloum, et al.. (2023). Prevalence of Underreported Nicotine Exposure Among US Nonsmoking Adults: A Comparison of Self-Reported Exposure and Serum Cotinine Levels From NHANES 2013–2020. Nicotine & Tobacco Research. 26(3). 298–306. 2 indexed citations

Fryer, Kimberly, Amanda L. Elmore, Jason L. Salemi, et al.. (2023). Access to Prenatal Care Among Patients With Opioid Use Disorder in Florida. Obstetrics and Gynecology. 142(5). 1162–1168. 2 indexed citations

Tagmount, Abderrahmane, Amin Sobh, Abdelrahman H. Elsayed, et al.. (2022). Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML. Blood Advances. 7(9). 1769–1783. 9 indexed citations

Luo, Huacheng, Ganqian Zhu, Melanie A. Eshelman, et al.. (2022). HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia. Molecular Cell. 82(4). 833–851.e11. 76 indexed citations

Uckun, Fatih M., Justin M. Watts, Alice S. Mims, et al.. (2021). Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436. Cancers. 13(21). 5287–5287. 7 indexed citations

Uckun, Fatih M., Tara L. Lin, Alice S. Mims, et al.. (2021). A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome. Cancers. 13(16). 4113–4113. 31 indexed citations

Keeley, Ellen C., Han Li, Christopher R. Cogle, et al.. (2021). Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial). The American Journal of Cardiology. 162. 1–5. 17 indexed citations

Chamala, Srikar, et al.. (2021). Building a precision oncology workforce by multidisciplinary and case-based learning. BMC Medical Education. 21(1). 75–75. 8 indexed citations

10.

Zhou, Yujia, et al.. (2020). Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia. Cancers. 12(12). 3710–3710. 8 indexed citations

11.

Uckun, Fatih M., Christopher R. Cogle, Tara L. Lin, et al.. (2019). A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia. Cancers. 12(1). 74–74. 26 indexed citations

12.

Lutfi, Forat, William Paul Skelton, Yu Wang, et al.. (2019). Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients. Hematology/Oncology and Stem Cell Therapy. 13(1). 23–31. 9 indexed citations

13.

Komrokji, Rami S., Najla H. Al Ali, Eric Padron, et al.. (2019). Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial. Clinical Lymphoma Myeloma & Leukemia. 19(4). 251–254. 3 indexed citations

14.

Davies, Jeff, Lisa Brennan, John R. Wingard, et al.. (2018). Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation. Clinical Cancer Research. 24(17). 4098–4109. 7 indexed citations

15.

Lutfi, Forat, William Paul Skelton, Nosha Farhadfar, et al.. (2017). Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center. Blood. 130. 4529–4529. 2 indexed citations

16.

Villa, Nancy, Ana Lemos de Matos, Tom Hofland, et al.. (2016). Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor. Molecular Therapy — Oncolytics. 4. 31–40. 26 indexed citations

17.

Villa, Nancy, Clive Wasserfall, Amy Meacham, et al.. (2015). Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells. Blood. 125(24). 3778–3788. 33 indexed citations

18.

Bartee, Eric, Amy Meacham, Elizabeth Wise, Christopher R. Cogle, & Grant McFadden. (2012). Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells. PLoS ONE. 7(8). e43298–e43298. 14 indexed citations

19.

Slayton, William B., Zhongbo Hu, Christopher R. Cogle, et al.. (2005). Developmental Differences in Megakaryocyte Maturation Are Determined by the Microenvironment. Stem Cells. 23(9). 1400–1408. 31 indexed citations

20.

Zander, Dani S., Maher Baz, Christopher R. Cogle, et al.. (2005). Bone Marrow-Derived Stem-Cell Repopulation Contributes Minimally to the Type II Pneumocyte Pool in Transplanted Human Lungs. Transplantation. 80(2). 206–212. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact